Navigation Links
Regulus Therapeutics to Present New Advancements in microRNA Therapeutics for Treatment of Metabolic Diseases and Cancer
Date:9/8/2011

In addition, Regulus collaborators Markus Stoffel, Ph.D., M.D. of ETH Zurich will be chairing a session titled "Targeting microRNA," and Thomas Thum, M.D., Ph.D. of Medical School Hannover, Germany will be presenting a talk on "Therapeutic targeting of individual cardiac cell types by microRNA antagonists."

Regulus is advancing multiple microRNA therapeutic programs to the clinic in the areas of fibrosis, immuno-inflammatory disease, metabolic disease, and oncology.

About microRNAs

The discovery of microRNA in humans during the last decade is one of the most exciting scientific breakthroughs in recent history. microRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not encode proteins but instead regulate gene expression. More than 700 microRNAs have been identified in the human genome, and over one-third of all human genes are believed to be regulated by microRNAs. A single microRNA can regulate entire networks of genes. As such, these molecules are considered master regulators of the human genome. microRNAs have been shown to play an integral role in numerous biological processes, including the immune response, cell-cycle control, metabolism, viral replication, stem cell differentiation and human development. Most microRNAs are conserved across multiple species, indicating the evolutionary importance of these molecules as modulators of critical biological pathways. Indeed, microRNA expression, or function, has been shown to be significantly altered in many disease states, including cancer, heart failure and viral infections. Targeting microRNAs with anti-miRs, antisense oligonucleotide inhibitors of microRNAs, or miR-mimics, double-stranded oligonucleotides to replace microRNA function opens potential for a novel class of therapeutics and offers a unique approach to treating disease by modulating entire biological pathways. To learn more abou
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Regulus Therapeutics and Collaborators from NYU Langone Medical Center Publish New Data Demonstrating Clearance of Cholesterol from Bloodstream and Reduction of Atherosclerotic Plaques through Inhibition of microRNA-33
2. Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 2015 Kalorama Information expects the nearly ... to grow well past the period where there ... a recent report.  The healthcare market research publisher ... efficiency improvements will grow the market seven to ... years.  The market for EMR systems continues to ...
(Date:4/27/2015)... April 27, 2015  Novira Therapeutics, Inc., a privately ... treatment of chronic hepatitis B virus (HBV) infection, today ... lead HBV core inhibitor candidate, NVR 3-778, at the ... Study of the Liver (EASL) in Vienna, ... NVR 3-778 from studies performed in a humanized UPA/SCID ...
(Date:4/27/2015)... China , April 27, 2015 ... "Company" or " China Jo-Jo "), a leading China-based ... care products through its online and retail pharmacies, today ... Ltd. ("Jiuzhou Pharmacy") has signed a new sales incentive ... owned subsidiary in China of ...
Breaking Medicine Technology:Kalorama: EMR Market Expected To Grow Beyond Incentives 2Kalorama: EMR Market Expected To Grow Beyond Incentives 3Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL 2Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL 3China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 2China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 3China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 4
... conjunction with DURECT Corporation,s (Nasdaq: DRRX ) third ... to listen to the conference call that will be ... 2009 at 4:30 pm Eastern Time (1:30 pm Pacific ... audio webcast of the presentation will be available by ...
... (TM) Links Thousands of Clinical Cardiovascular Practices to ... WASHINGTON, Oct. 26 The American College of ... Network(TM), the first-ever registry-based cardiovascular network to link ... to the ACC,s National Cardiovascular Data Registry(R) (NCDR), ...
Cached Medicine Technology:DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call 2American College of Cardiology Launches the Nation's First Registry-Based Cardiovascular Practice Network 2American College of Cardiology Launches the Nation's First Registry-Based Cardiovascular Practice Network 3
(Date:4/27/2015)... Doctors on Liens has been the go ... over twenty years. So when attorneys of personal injury victims ... the Fresno area , Doctors on Liens responded with the ... medical specialists. With a medical group of chiropractors, an ... is now helping more personal injury victims than ever. ...
(Date:4/27/2015)... Columbus, OH (PRWEB) April 27, 2015 ... insurance to help his clients feel secure, but also helps ... a.m. to 7 p.m., Douglas will be manning a booth ... Expo Center, Lausche Building, 717 E. 17th Ave., Columbus, Ohio. ... this worthy event that will feature hundreds of adoptable pets ...
(Date:4/27/2015)... On May 15, Mount Soma Ashram students ... to raise awareness of the vision of Mount Soma; ... Temple. Ironically, when many of these people moved to ... they were leaving the social and technological world behind. ... meditation, service to a higher cause, deep introspection, and ...
(Date:4/27/2015)... 27, 2015 Attorney Dan Newlin, of the ... and protecting his clients, took that commitment to a whole ... code which makes it easier for existing and potential clients ... building his brand and added value to the firm’s services, ... area where Newlin has law offices. , “I knew the ...
(Date:4/27/2015)... Texas has saved $433 million by ... to providing drug offenders with addiction treatment, according to ... 8th. Several states, including Massachusetts, are considering adopting justice ... has formed community recovery programs to help redress rampant ... of State Governments WA, ID, NE, KS, MI, ...
Breaking Medicine News(10 mins):Health News:Eminent Doctor Joins Forces with Doctors on Liens in Fresno 2Health News:Farmers Insurance Agent Douglas Fitzpatrick Ensures Pets Find Homes 2Health News:Mount Soma Monks Do Social Media 2Health News:Dan Newlin Hashtags It With #Dan 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 3
... Dr Andrew Wakefield, finds firstly that MMR vaccine was found ... others findings now supports// it saying (measles has been found ... ,Dr Stephen Walker, of Wake Forest University ... between autistic children with bowel disease and measles virus and ...
... Dr. Ronald E. Cranford, 65, a neurologist and brain injury ... establish clearer standards to determine whether a patient was in ... to his family the cause of death was complications of ... advocate for the right of terminally ill patients to end ...
... has revealed that preterm babies between 34 and 36 weeks ... disorder. ,Babies born at even less ... ADHD. ,The study conducted by Danish Researchers is based on ... in Childhood which revealed an increased occurrence of ADHD ...
... India on par with South Africa. It has been revealed ... HIV infected people//. ,The number of people living ... Global AIDS Epidemic is 5.7 million. This estimate has included ... whereupon the Indian HIV infected population number has risen by ...
... The provincial government has permitted the Alberta pharmacists to ... But drugs under the narcotics category or addictive drugs ... beginning fall, pharmacists who have undergone a full-fledged training ... high blood pressure. ,This is slated to spruce ...
... World Congress on Osteoporosis (IOF WCO), the world's largest ... opened on Friday June 2, in Toronto, Canada//. ... Scientific Committee, noted that this year's congress attracted 720 ... congress held in 2004 in Rio de Janeiro, Brazil. ...
Cached Medicine News:Health News:Renowned Doctor Passes Away 2Health News:Premature Birth Could Lead to ADHD 2
Inquire...
Inquire...
Inquire...
The modular, high-end stereomicroscope; meets even the most critical demands in research and quality control provides high-contrast images with excellent depth of field and color fidelity...
Medicine Products: